Canadian rheumatoid arthritis guidelines address specific drug safety concernsDocument addresses several specific safety concerns related to the use of traditional and biologic DMARDs in patients. Cancer rates four times higher in juvenile arthritisBut use of TNF inhibitors not to blame, researcher says Autoimmune disease raises pulmonary embolism risk Anticoagulants could be warranted, Swedish researchers suggest Alternative medicines popular among rheumatoid arthritis patients Physicians need to be aware of treatments—such as gin-soaked raisins—and potential interactions with conventional medications Timing of biologics cut-off for surgery requires study Rheumatoid arthritis treatment is typically being stopped weeks before procedure despite half-lives of drugs being much shorter Biologics have lasting power in rheumatoid arthritis But recommended starting dose is not effective, Canadian researcher notes Anti-TNF agents similarly effective in rheumatoid arthritis Words describe pain as well as pictures can Fibromyalgia study shows checkbox format provides a reliable measure of pain Clinical Notes: New guidelines for rheumatoid arthritis Promote best practices, improved healthcare delivery for persons with rheumatoid arthritis New Canadian guidelines for managing rheumatoid arthritis List of recommendations aims to promote best practices and improve healthcare delivery for those with RA. First Previous 16 17 18 19 20 Next Last
